![]() Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. | Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. | ![]() Strategic Partners Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies. | |
Founding Date | Founding Date 1988 | Founding Date 2003 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Leiden, NL HQ Leiden, NL | Locations San Diego, US HQ | Locations København, DK HQ Chicago, US Newton, US |
Employees | Employees 404 | Employees 70 | Employees 1 |
Valuation ($) | Valuation ($) 590.3 m | Valuation ($) 1.8 b | Valuation ($) 6.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) $7.4m (FY, 2022) | Revenue (est.) kr309k (FY, 2025) |
Cost of goods | Cost of goods $41.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $341m (FY, 2025) | Gross profit N/A | Gross profit kr309k (FY, 2025) |
Net income | Net income $2.5m (FY, 2025) | Net income ($78m) (FY, 2022) | Net income (kr859k) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 347.9m | Total funding raised $ 58.8m |
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
View company
Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies.
View company